Larotrectinib in Adjuvant and First‐Line Treatment for Metastatic NTRK Fusion Colon Cancer
Year: 2026
Type: article
Study design: Case Report
DOI: 10.1111/ajco.70072
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7125497932
